首页 > 最新文献

MDM Policy and Practice最新文献

英文 中文
Prioritizing Patients from the Most Deprived Areas on Elective Waiting Lists in the NHS in England: Estimating the Health and Health Inequality Impact. 优先考虑来自最贫困地区的患者在英国国民保健服务候诊名单:估计健康和健康不平等的影响。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-21 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241310146
Naomi Kate Gibbs, Susan Griffin, Nils Gutacker, Adrián Villaseñor, Simon Walker

Introduction. Reducing hospital waiting lists for elective procedures is a policy concern in the National Health Service (NHS) in England. Following growth in waiting lists after COVID-19, the NHS published an elective recovery plan that includes an aim to prioritize patients from deprived areas. We use a previously developed model to estimate the health and health inequality impact under hypothetical targeted versus universal policies to reduce waiting time. Methods. We use a Markov model to estimate the health impact of waiting, by index of multiple deprivation quintile group, for 8 elective procedures. We estimate patients' remaining quality-adjusted life-years (QALYs) with baseline waiting times and under 2 hypothetical policy scenarios: 1) a universal policy in which all patients receive an equal reduction in wait and 2) a targeted policy in which patients living in the most deprived quintile are prioritized. We estimate individual and population level health under each of the 2 policies and compare it with baseline. We also estimate how health inequality changes from baseline using the slope index of inequality, reflecting the difference in health between the least and most deprived quintile based on QALYs. Results. A universal reduction in waiting time is estimated to improve overall population health but increase health inequality. A targeted reduction would achieve nearly the same overall health gain and would also increase population-level health inequalities but to a lesser extent than the universal policy would. Discussion. If the NHS is successful in prioritizing patients on waiting lists from the most deprived areas, this may result in smaller increases in health inequalities while maintaining a similar level of overall health gain compared with a universal policy.

Highlights: The NHS elective recovery plans include prioritizing patients who live in the most deprived areas of England.Evaluating a hypothetical targeted wait time reduction policy against a universal wait time reduction policy suggests almost the same level of population health gain could be achieved while lessening the negative impact on health inequality.Expected outcomes of government health policies should be quantified to explore the impact on both health maximization and health inequality minimization, as both represent legitimate policy concerns.

介绍。减少医院候诊名单的选择性程序是一个政策关注的国家卫生服务(NHS)在英格兰。随着COVID-19后等待名单的增加,NHS发布了一项选择性恢复计划,其中包括优先考虑来自贫困地区的患者。我们使用先前开发的模型来估计在假设的目标政策与普遍政策下减少等待时间的健康和健康不平等影响。方法。我们使用马尔可夫模型,通过多重剥夺五分位数组的指数来估计8种选择性手术的等待对健康的影响。我们根据基线等待时间和两种假设政策情景估计患者的剩余质量调整生命年(QALYs): 1)所有患者获得同等等待时间减少的普遍政策和2)优先考虑生活在最贫困五分之一的患者的目标政策。我们估计了两种政策下的个人和人群健康水平,并将其与基线进行比较。我们还使用不平等的斜率指数来估计健康不平等如何从基线变化,反映基于质量年的最贫困和最贫困五分之一之间的健康差异。结果。据估计,普遍减少等待时间将改善总体人口健康,但也会增加健康不平等。有针对性的减少将实现几乎相同的总体健康收益,也将增加人口一级的健康不平等,但程度低于普遍政策。讨论。如果国民保健制度成功地将最贫困地区的病人排在等候名单上,这可能导致保健不平等的增加幅度较小,同时与普遍政策相比,保持类似水平的总体健康收益。亮点:NHS选择性恢复计划包括优先考虑生活在英格兰最贫困地区的患者。将假设的有针对性的减少等待时间政策与普遍的减少等待时间政策进行评估表明,在减少对健康不平等的负面影响的同时,可以实现几乎相同水平的人口健康收益。应量化政府卫生政策的预期结果,以探讨对健康最大化和健康不平等最小化的影响,因为两者都是合理的政策关切。
{"title":"Prioritizing Patients from the Most Deprived Areas on Elective Waiting Lists in the NHS in England: Estimating the Health and Health Inequality Impact.","authors":"Naomi Kate Gibbs, Susan Griffin, Nils Gutacker, Adrián Villaseñor, Simon Walker","doi":"10.1177/23814683241310146","DOIUrl":"10.1177/23814683241310146","url":null,"abstract":"<p><p><b>Introduction.</b> Reducing hospital waiting lists for elective procedures is a policy concern in the National Health Service (NHS) in England. Following growth in waiting lists after COVID-19, the NHS published an elective recovery plan that includes an aim to prioritize patients from deprived areas. We use a previously developed model to estimate the health and health inequality impact under hypothetical targeted versus universal policies to reduce waiting time. <b>Methods.</b> We use a Markov model to estimate the health impact of waiting, by index of multiple deprivation quintile group, for 8 elective procedures. We estimate patients' remaining quality-adjusted life-years (QALYs) with baseline waiting times and under 2 hypothetical policy scenarios: 1) a universal policy in which all patients receive an equal reduction in wait and 2) a targeted policy in which patients living in the most deprived quintile are prioritized. We estimate individual and population level health under each of the 2 policies and compare it with baseline. We also estimate how health inequality changes from baseline using the slope index of inequality, reflecting the difference in health between the least and most deprived quintile based on QALYs. <b>Results.</b> A universal reduction in waiting time is estimated to improve overall population health but increase health inequality. A targeted reduction would achieve nearly the same overall health gain and would also increase population-level health inequalities but to a lesser extent than the universal policy would. <b>Discussion.</b> If the NHS is successful in prioritizing patients on waiting lists from the most deprived areas, this may result in smaller increases in health inequalities while maintaining a similar level of overall health gain compared with a universal policy.</p><p><strong>Highlights: </strong>The NHS elective recovery plans include prioritizing patients who live in the most deprived areas of England.Evaluating a hypothetical targeted wait time reduction policy against a universal wait time reduction policy suggests almost the same level of population health gain could be achieved while lessening the negative impact on health inequality.Expected outcomes of government health policies should be quantified to explore the impact on both health maximization and health inequality minimization, as both represent legitimate policy concerns.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241310146"},"PeriodicalIF":1.9,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis. 一致性和共享肺癌筛查决策与决策冲突的关联:一项多机构横断面分析。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-17 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241309945
Donald R Sullivan, Sara E Golden, Liana Schweiger, Anne C Melzer, Santanu Datta, James M Davis, Renda Soylemez Wiener, Christopher G Slatore

Introduction. Many organizations recommend structured communication processes, including formal shared decision making (SDM), for patients undergoing lung cancer screening (LCS) using low-dose computed tomography (LDCT). We sought to understand if concordant and shared LCS decision making was associated with decisional conflict. Methods. In this prospective, observational study, we enrolled patients from 3 medical centers (2 Veterans Health Administration, 1 academic facility) after a decision-making interaction about undergoing LCS but before receiving the LDCT. We included patients who indicated they accepted or declined to undergo the LDCT. We evaluated preferred and actual decision-making roles and used multivariable linear and logistic regression models to measure the association of concordant (congruence between actual and preferred roles) and shared LCS decision making with decisional conflict to report adjusted odds ratios (AOR). Results. Of the 409 participants with nonmissing information, 83% reported LCS decision-making role concordance. In addition, 223 (58%) reported an indeterminate level and 56 (14%) reported decisional conflict. LCS decision-making role concordance was not associated with decisional conflict (AOR = 0.86, 95% confidence interval [CI]: 0.38-1.94, P = 0.71) compared with role discordance. Participant-reported actual LCS SDM role was not associated with decisional conflict (AOR = 0.99, 95% CI: 0.51-1.93, P = 0.98) compared with patient- or provider-controlled roles. Conclusions. LCS decisional conflict was uncommon, although many patients reported an indeterminate level of decisional conflict. Neither concordant nor shared LCS decision-making role was associated with decisional conflict. Clinicians may be unable to decrease LCS decisional conflict using efforts to enhance decision-making interactions.

Highlights: We evaluated patients' preferred and actual decision-making role and decisional conflict following a decision-making interaction about lung cancer screening (LCS).Concordant decision-making preference was not associated with decisional conflict.Actual decision-making role was also not associated with decisional conflict.Efforts to enhance decision-making interactions may not decrease LCS decisional conflict.

介绍。许多组织推荐结构化的沟通过程,包括正式的共享决策(SDM),用于使用低剂量计算机断层扫描(LDCT)进行肺癌筛查(LCS)的患者。我们试图了解和谐和共享的LCS决策是否与决策冲突有关。方法。在这项前瞻性观察性研究中,我们招募了来自3个医疗中心(2个退伍军人健康管理局,1个学术机构)的患者,这些患者在接受LDCT之前接受了LCS的决策互动。我们纳入了接受或拒绝行LDCT的患者。我们评估了首选决策角色和实际决策角色,并使用多变量线性和逻辑回归模型来测量一致性(实际角色和首选角色之间的一致性)和共享LCS决策与决策冲突的关联,以报告调整优势比(AOR)。结果。在409名信息不缺失的参与者中,83%的人报告了LCS决策角色的一致性。此外,223人(58%)报告了不确定的水平,56人(14%)报告了决策冲突。与角色不一致性相比,LCS决策角色一致性与决策冲突不相关(AOR = 0.86, 95%可信区间[CI]: 0.38-1.94, P = 0.71)。与患者或提供者控制的角色相比,参与者报告的实际LCS SDM角色与决策冲突无关(AOR = 0.99, 95% CI: 0.51-1.93, P = 0.98)。结论。LCS决策冲突并不常见,尽管许多患者报告了不确定水平的决策冲突。和谐型和共享型LCS决策角色与决策冲突均不相关。临床医生可能无法通过努力加强决策互动来减少LCS决策冲突。重点:我们评估了患者在肺癌筛查(LCS)决策互动后的首选和实际决策角色以及决策冲突。一致性决策偏好与决策冲突不相关。实际决策角色也与决策冲突无关。加强决策互动的努力可能不会减少LCS决策冲突。
{"title":"Associations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis.","authors":"Donald R Sullivan, Sara E Golden, Liana Schweiger, Anne C Melzer, Santanu Datta, James M Davis, Renda Soylemez Wiener, Christopher G Slatore","doi":"10.1177/23814683241309945","DOIUrl":"10.1177/23814683241309945","url":null,"abstract":"<p><p><b>Introduction.</b> Many organizations recommend structured communication processes, including formal shared decision making (SDM), for patients undergoing lung cancer screening (LCS) using low-dose computed tomography (LDCT). We sought to understand if concordant and shared LCS decision making was associated with decisional conflict. <b>Methods.</b> In this prospective, observational study, we enrolled patients from 3 medical centers (2 Veterans Health Administration, 1 academic facility) after a decision-making interaction about undergoing LCS but before receiving the LDCT. We included patients who indicated they accepted or declined to undergo the LDCT. We evaluated preferred and actual decision-making roles and used multivariable linear and logistic regression models to measure the association of concordant (congruence between actual and preferred roles) and shared LCS decision making with decisional conflict to report adjusted odds ratios (AOR). <b>Results.</b> Of the 409 participants with nonmissing information, 83% reported LCS decision-making role concordance. In addition, 223 (58%) reported an indeterminate level and 56 (14%) reported decisional conflict. LCS decision-making role concordance was not associated with decisional conflict (AOR = 0.86, 95% confidence interval [CI]: 0.38-1.94, <i>P</i> = 0.71) compared with role discordance. Participant-reported actual LCS SDM role was not associated with decisional conflict (AOR = 0.99, 95% CI: 0.51-1.93, <i>P</i> = 0.98) compared with patient- or provider-controlled roles. <b>Conclusions.</b> LCS decisional conflict was uncommon, although many patients reported an indeterminate level of decisional conflict. Neither concordant nor shared LCS decision-making role was associated with decisional conflict. Clinicians may be unable to decrease LCS decisional conflict using efforts to enhance decision-making interactions.</p><p><strong>Highlights: </strong>We evaluated patients' preferred and actual decision-making role and decisional conflict following a decision-making interaction about lung cancer screening (LCS).Concordant decision-making preference was not associated with decisional conflict.Actual decision-making role was also not associated with decisional conflict.Efforts to enhance decision-making interactions may not decrease LCS decisional conflict.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241309945"},"PeriodicalIF":1.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of Diminishing Lifespan Marginal Utility for Valuing Equity in Cost-Effectiveness Analysis. 寿命边际效用递减对成本效益分析中权益评估的影响。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-17 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241305106
R Scott Braithwaite

Introduction. Diminishing marginal lifespan utility (DMLU) implies that a particular lifespan increment (e.g., 1 life-year) confers lesser marginal utility if added to longer lifespans (e.g., 90 y to 91 y) than to shorter lifespans (e.g., 60 y to 61 y) if quality of life is unchanged. Because DMLU is difficult to disambiguate from discounting, risk attitude, and other elements of utility "curvature," it is poorly characterized. However, the imperative to consider equity in cost-effectiveness analysis (CEA) renders its characterization more important. Methods. I add certainty to the characterization of DMLU through literature review and illustrative example. The literature review synthesizes stated preference studies of utility curvature that exclude risk or probability. The example compares alternative valuations of approaches to reduce inequality in cystic fibrosis outcomes between US centers serving mostly White patients and centers serving mostly non-Black Hispanic patients, with versus without DMLU. Results. The existence of DMLU is likely, and empirical data support its relevance over typical CEA time horizons. The imperative to consider equity in CEA magnifies the importance of DMLU for several reasons. First, intergenerational CEAs require lower discount rates that are less likely to incidentally absorb DMLU. Second, DMLU is incompatible with the use of absolute measures of inequality aversion. Third, DMLU may bias the interpretation of relative measures of inequality aversion toward prioritarianism. Finally, not considering DMLU implicitly biases life-year-based metrics against equity. Conclusion. DMLU is likely to exist, can benefit from additional characterization, and may merit inclusion in CEA alongside discounting. Omitting consideration of DMLU will sometimes confer an antiequity bias and may affect the interpretation of CEAs incorporating inequality aversion.

Highlights: Diminishing marginal lifespan utility (DMLU) means that the value of extending lifespan may differ based on the duration of life already lived.DMLU is not typically considered in cost-effectiveness analyses.Not considering DMLU may bias cost-effectiveness analyses against equity.Not considering DMLU may reduce the accuracy of distributive cost-effectiveness analyses and other approaches to consider equity along with efficiency.

介绍。边际寿命效用递减(DMLU)意味着,在生活质量不变的情况下,一个特定的寿命增量(例如,1个生命年)如果增加到较长的寿命(例如,90岁至91岁)中,其边际效用要小于增加到较短的寿命(例如,60岁至61岁)中。因为DMLU很难从贴现、风险态度和其他效用“曲率”元素中消除歧义,所以它的特征很差。然而,在成本效益分析(CEA)中考虑公平性的必要性使得其表征更加重要。方法。我通过文献综述和举例说明来增加对DMLU特征的确定性。文献综述综合了排除风险或概率的效用曲率的陈述偏好研究。本例比较了在美国主要为白人患者服务的中心和主要为非黑人西班牙裔患者服务的中心之间,在有和没有DMLU的情况下,减少囊性纤维化结果不平等的方法的不同估值。结果。DMLU的存在是可能的,并且经验数据支持其在典型CEA时间范围内的相关性。考虑CEA公平性的必要性放大了DMLU的重要性,原因有几个。首先,代际cea需要较低的贴现率,从而不太可能偶然吸收DMLU。其次,DMLU与使用厌恶不平等的绝对衡量标准是不相容的。第三,DMLU可能会使对不平等厌恶的相对衡量标准的解释偏向优先主义。最后,不考虑DMLU会使基于生命周期的指标与公平相冲突。结论。DMLU可能存在,可以从额外的表征中受益,并且可能值得将其包含在CEA中并进行折扣。忽略对DMLU的考虑有时会产生反公平偏见,并可能影响对包含不平等厌恶的cea的解释。重点:边际寿命效用递减(DMLU)意味着延长寿命的价值可能会根据已经活过的生命的持续时间而有所不同。在成本效益分析中通常不考虑DMLU。不考虑DMLU可能会使成本效益分析偏向于公平。不考虑DMLU可能会降低分配成本效益分析和其他考虑公平和效率的方法的准确性。
{"title":"Implications of Diminishing Lifespan Marginal Utility for Valuing Equity in Cost-Effectiveness Analysis.","authors":"R Scott Braithwaite","doi":"10.1177/23814683241305106","DOIUrl":"10.1177/23814683241305106","url":null,"abstract":"<p><p><b>Introduction.</b> Diminishing marginal lifespan utility (DMLU) implies that a particular lifespan increment (e.g., 1 life-year) confers lesser marginal utility if added to longer lifespans (e.g., 90 y to 91 y) than to shorter lifespans (e.g., 60 y to 61 y) if quality of life is unchanged. Because DMLU is difficult to disambiguate from discounting, risk attitude, and other elements of utility \"curvature,\" it is poorly characterized. However, the imperative to consider equity in cost-effectiveness analysis (CEA) renders its characterization more important. <b>Methods.</b> I add certainty to the characterization of DMLU through literature review and illustrative example. The literature review synthesizes stated preference studies of utility curvature that exclude risk or probability. The example compares alternative valuations of approaches to reduce inequality in cystic fibrosis outcomes between US centers serving mostly White patients and centers serving mostly non-Black Hispanic patients, with versus without DMLU. <b>Results.</b> The existence of DMLU is likely, and empirical data support its relevance over typical CEA time horizons. The imperative to consider equity in CEA magnifies the importance of DMLU for several reasons. First, intergenerational CEAs require lower discount rates that are less likely to incidentally absorb DMLU. Second, DMLU is incompatible with the use of absolute measures of inequality aversion. Third, DMLU may bias the interpretation of relative measures of inequality aversion toward prioritarianism. Finally, not considering DMLU implicitly biases life-year-based metrics against equity. <b>Conclusion.</b> DMLU is likely to exist, can benefit from additional characterization, and may merit inclusion in CEA alongside discounting. Omitting consideration of DMLU will sometimes confer an antiequity bias and may affect the interpretation of CEAs incorporating inequality aversion.</p><p><strong>Highlights: </strong>Diminishing marginal lifespan utility (DMLU) means that the value of extending lifespan may differ based on the duration of life already lived.DMLU is not typically considered in cost-effectiveness analyses.Not considering DMLU may bias cost-effectiveness analyses against equity.Not considering DMLU may reduce the accuracy of distributive cost-effectiveness analyses and other approaches to consider equity along with efficiency.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241305106"},"PeriodicalIF":1.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing Masks and Random Screening Test Usage within K-12 Schools. 优化口罩和随机筛选测试在K-12学校的使用。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-17 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241312225
Yiwei Zhang, Maria E Mayorga, Julie S Ivy, Julie L Swann

Background. COVID-19 tremendously disrupted the global health system. People of all ages were at risk of becoming infected. Frequent school closures raised concerns about both the physical and mental health of school-age children. Many studies discussed the effectiveness of various interventions, while few focused on optimizing such interventions. Methods. This study aimed to optimize the usage of random screening tests and masking requirements within K-12 schools. We simulated the disease transmission within a school setting and sought to find the most efficient schedules for schools to arrange their weekly screening tests and mask mandates. The goal was to minimize the number of the end-of-semester infections as well as to use the minimum number of resources. We applied the nondominated sorting genetic algorithm, NSGA-II, to solve this multiobjective optimization problem. We also compared results when polymerase chain reaction (PCR) versus rapid antigen tests were used. Results. The NSGA successfully found Pareto solutions when optimizing the end-of-semester infections, the total number of tests, and the total number of weeks masking. The screening tests and masks can serve as alternatives to one another when prioritizing minimizing the number of infections. In addition, due to the faster return of testing results and lower accuracy, the rapid antigen tests had a similar effect as PCR tests. Conclusion. Our study provides policy makers in K-12 schools with valuable insights. The conclusions derived from this research can serve as a solid foundation for making informative decisions regarding random screening tests and universal masking policies.

Highlights: Our simulation optimization framework was used to design weekly schedules for random screening tests and masking within K-12 schools to mitigate COVID-19 infections.We considered multiple objectives and applied the NSGA-II algorithm to find a Pareto solution set.Based on local context and preferences, decision makers can trade off testing and masking to achieve a similar number of end-of-semester infections.When a few weeks of masks are mandated, it is best to use them at the beginning of a semester.

背景。COVID-19严重扰乱了全球卫生系统。所有年龄段的人都有被感染的危险。学校频繁关闭引起了人们对学龄儿童身心健康的关注。许多研究讨论了各种干预措施的有效性,而很少关注于优化这些干预措施。方法。本研究旨在优化K-12学校随机筛选测试和屏蔽要求的使用。我们模拟了疾病在学校环境中的传播,并试图找到学校安排每周筛查测试和口罩要求的最有效时间表。目标是尽量减少学期末的感染人数,并使用最少的资源。我们采用非支配排序遗传算法NSGA-II来解决这一多目标优化问题。我们还比较了聚合酶链反应(PCR)和快速抗原检测的结果。结果。NSGA在优化学期末感染、总检测次数和总掩蔽周数时成功地找到了帕累托解。在优先减少感染人数时,筛查测试和口罩可以相互替代。此外,由于检测结果返回速度较快,准确性较低,抗原快速检测的效果与PCR检测相似。结论。我们的研究为K-12学校的政策制定者提供了有价值的见解。从这项研究中得出的结论可以作为制定关于随机筛查测试和通用屏蔽政策的信息决策的坚实基础。重点:我们的模拟优化框架用于设计K-12学校随机筛选测试和屏蔽的每周时间表,以减轻COVID-19感染。我们考虑了多个目标,并应用NSGA-II算法寻找Pareto解集。根据当地情况和偏好,决策者可以权衡测试和掩盖,以达到相似的学期末感染数量。如果有几个星期的口罩是强制性的,最好在学期开始时使用。
{"title":"Optimizing Masks and Random Screening Test Usage within K-12 Schools.","authors":"Yiwei Zhang, Maria E Mayorga, Julie S Ivy, Julie L Swann","doi":"10.1177/23814683241312225","DOIUrl":"10.1177/23814683241312225","url":null,"abstract":"<p><p><b>Background.</b> COVID-19 tremendously disrupted the global health system. People of all ages were at risk of becoming infected. Frequent school closures raised concerns about both the physical and mental health of school-age children. Many studies discussed the effectiveness of various interventions, while few focused on optimizing such interventions. <b>Methods.</b> This study aimed to optimize the usage of random screening tests and masking requirements within K-12 schools. We simulated the disease transmission within a school setting and sought to find the most efficient schedules for schools to arrange their weekly screening tests and mask mandates. The goal was to minimize the number of the end-of-semester infections as well as to use the minimum number of resources. We applied the nondominated sorting genetic algorithm, NSGA-II, to solve this multiobjective optimization problem. We also compared results when polymerase chain reaction (PCR) versus rapid antigen tests were used. <b>Results.</b> The NSGA successfully found Pareto solutions when optimizing the end-of-semester infections, the total number of tests, and the total number of weeks masking. The screening tests and masks can serve as alternatives to one another when prioritizing minimizing the number of infections. In addition, due to the faster return of testing results and lower accuracy, the rapid antigen tests had a similar effect as PCR tests. <b>Conclusion.</b> Our study provides policy makers in K-12 schools with valuable insights. The conclusions derived from this research can serve as a solid foundation for making informative decisions regarding random screening tests and universal masking policies.</p><p><strong>Highlights: </strong>Our simulation optimization framework was used to design weekly schedules for random screening tests and masking within K-12 schools to mitigate COVID-19 infections.We considered multiple objectives and applied the NSGA-II algorithm to find a Pareto solution set.Based on local context and preferences, decision makers can trade off testing and masking to achieve a similar number of end-of-semester infections.When a few weeks of masks are mandated, it is best to use them at the beginning of a semester.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241312225"},"PeriodicalIF":1.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Working toward Personalized Intervention Advice: A Survey Study on Preference Heterogeneity in Patients with Breast Cancer-Related Fatigue. 致力于个性化干预建议:乳腺癌相关疲劳患者偏好异质性的调查研究。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241309676
Lian Beenhakker, Kim A E Wijlens, Christina Bode, Miriam M R Vollenbroek-Hutten, Sabine Siesling, Janine A van Til, Annemieke Witteveen

Introduction. Many breast cancer survivors experience cancer-related fatigue (CRF), and several interventions to treat CRF are available. One way to tailor intervention advice is based on patient preferences. In this study, we explore preference heterogeneity regarding between-attribute and within-attribute preferences. In addition, we propose simple decision rules to match preferences to interventions. Methods. Nine attributes were included with dichotomized levels. Participants selected their preferred level per attribute and ranked the attributes using best-worst scaling. Between-attribute and within-attribute preferences were determined, together with their heterogeneity. Using decision rules, matching scores were calculated for a hypothetical intervention. Results. Sixty-seven breast cancer survivors completed the survey. They were on average 52 y old, 4.5 y after diagnosis, experienced CRF (6.5-7.2/10) on 3 dimensions (physical, mental, and emotional), and 43% already followed an intervention for CRF. Overall, participants ranked costs highest. Next to costs, proven effectiveness and type of intervention were also frequently ranked first. Only 13 participants (19%) shared the most common preference pattern of shorter interventions, daily sessions, shorter session time, a psychosocial intervention, no anonymity, and contact with a therapist and peers. Matching scores for a hypothetical intervention with attributes corresponding with the overall within-attribute preferences varied from 44% to 100%. Conclusion. A large heterogeneity in preferences of breast cancer survivors for CRF intervention attributes was demonstrated. Using simple decision rules, the effect of this heterogeneity on linking preferences to interventions with matching scores was demonstrated. Implications. Personalization of intervention advice is necessary due to preference heterogeneity. Tailored advice can result in higher involvement of patients in decision making, intervention adherence and satisfaction, and subsequently a potential higher quality of life after breast cancer.

Highlights: Many breast cancer survivors experience cancer-related fatigue for which many interventions exist.Our results show large preference heterogeneity in breast cancer patients' preferences for attributes of eHealth interventions.Based on this preference heterogeneity, intervention advice for cancer-related fatigue after breast cancer can be personalized, ultimately improving quality of life after breast cancer.

介绍。许多乳腺癌幸存者经历癌症相关疲劳(CRF),有几种治疗CRF的干预措施。有一种方法是根据病人的偏好来定制干预建议。在本研究中,我们探讨了属性间偏好和属性内偏好的异质性。此外,我们提出了简单的决策规则,将偏好与干预相匹配。方法。将9个属性分为二分类级别。参与者选择每个属性的首选级别,并使用最佳最差缩放对属性进行排名。确定了属性间偏好和属性内偏好,以及它们的异质性。使用决策规则,为假设的干预计算匹配分数。结果。67名乳腺癌幸存者完成了这项调查。他们的平均年龄为52岁,诊断后4.5岁,在3个维度(身体、精神和情感)上经历了CRF(6.5-7.2/10), 43%的人已经接受了CRF干预。总体而言,参与者将成本排在首位。除了成本之外,经证实的有效性和干预措施类型也经常排在第一位。只有13名参与者(19%)分享了最常见的偏好模式,即较短的干预、每日治疗、较短的治疗时间、心理社会干预、不匿名、与治疗师和同伴联系。与总体属性内偏好相对应的假设干预的属性匹配得分从44%到100%不等。结论。研究表明,乳腺癌幸存者对CRF干预属性的偏好存在很大的异质性。使用简单的决策规则,证明了这种异质性对将偏好与匹配分数的干预联系起来的影响。的影响。由于偏好异质性,个性化干预建议是必要的。量身定制的建议可以提高患者对决策的参与度,干预依从性和满意度,从而提高乳腺癌后的生活质量。重点:许多乳腺癌幸存者经历与癌症相关的疲劳,目前存在许多干预措施。我们的研究结果显示,乳腺癌患者对电子健康干预属性的偏好存在很大的异质性。基于这种偏好异质性,乳腺癌后癌症相关疲劳的干预建议可以个性化,最终提高乳腺癌后的生活质量。
{"title":"Working toward Personalized Intervention Advice: A Survey Study on Preference Heterogeneity in Patients with Breast Cancer-Related Fatigue.","authors":"Lian Beenhakker, Kim A E Wijlens, Christina Bode, Miriam M R Vollenbroek-Hutten, Sabine Siesling, Janine A van Til, Annemieke Witteveen","doi":"10.1177/23814683241309676","DOIUrl":"10.1177/23814683241309676","url":null,"abstract":"<p><p><b>Introduction.</b> Many breast cancer survivors experience cancer-related fatigue (CRF), and several interventions to treat CRF are available. One way to tailor intervention advice is based on patient preferences. In this study, we explore preference heterogeneity regarding between-attribute and within-attribute preferences. In addition, we propose simple decision rules to match preferences to interventions. <b>Methods.</b> Nine attributes were included with dichotomized levels. Participants selected their preferred level per attribute and ranked the attributes using best-worst scaling. Between-attribute and within-attribute preferences were determined, together with their heterogeneity. Using decision rules, matching scores were calculated for a hypothetical intervention. <b>Results.</b> Sixty-seven breast cancer survivors completed the survey. They were on average 52 y old, 4.5 y after diagnosis, experienced CRF (6.5-7.2/10) on 3 dimensions (physical, mental, and emotional), and 43% already followed an intervention for CRF. Overall, participants ranked <i>costs</i> highest. Next to <i>costs</i>, <i>proven</i> <i>effectiveness</i> and <i>type of intervention</i> were also frequently ranked first. Only 13 participants (19%) shared the most common preference pattern of shorter interventions, daily sessions, shorter session time, a psychosocial intervention, no anonymity, and contact with a therapist and peers. Matching scores for a hypothetical intervention with attributes corresponding with the overall within-attribute preferences varied from 44% to 100%. <b>Conclusion.</b> A large heterogeneity in preferences of breast cancer survivors for CRF intervention attributes was demonstrated. Using simple decision rules, the effect of this heterogeneity on linking preferences to interventions with matching scores was demonstrated. <b>Implications.</b> Personalization of intervention advice is necessary due to preference heterogeneity. Tailored advice can result in higher involvement of patients in decision making, intervention adherence and satisfaction, and subsequently a potential higher quality of life after breast cancer.</p><p><strong>Highlights: </strong>Many breast cancer survivors experience cancer-related fatigue for which many interventions exist.Our results show large preference heterogeneity in breast cancer patients' preferences for attributes of eHealth interventions.Based on this preference heterogeneity, intervention advice for cancer-related fatigue after breast cancer can be personalized, ultimately improving quality of life after breast cancer.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241309676"},"PeriodicalIF":1.9,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Soda Tax on Obesity and Diabetes in California: A Cost-Effectiveness Analysis. 加州汽水税对肥胖和糖尿病的影响:成本-效果分析。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1177/23814683241309669
Fan Zhao, Risha Gidwani, May C Wang, Liwei Chen, Roch A Nianogo

Introduction. Consumption of sugar-sweetened beverages (SSBs) contributes to weight gain, obesity, and diabetes. Soda tax has been proposed to reduce consumption of SSBs. What remains unclear is whether the soda tax has an effect on health and health care costs. We evaluated the cost-effectiveness of a 1-cent-per-ounce soda tax on obesity and diabetes in California. Methods. A microsimulation state-transition model was used to evaluate the cost-effectiveness of the soda tax. Health outcomes were measured in quality-adjusted life-years (QALYs). Health care costs were projected from 2015 to 2035. Results. In a simulated cohort of Californian adults, the soda tax policy prevented 2.28 million cases of overweight (95% confidence interval [CI] -0.06 to 6.63) and 0.49 million cases of obesity (95% CI -0.19 to 1.18). From the health care perspective, the incremental cost-effectiveness ratio of the soda tax was $124,839 dollars per QALY (95% CI -1,151,983 to 557,660). From the health care perspective, the soda tax policy was cost-effective 80% of the time in the probabilistic sensitivity analysis using a willingness-to-pay threshold of $100,000 per QALY. Conclusions. The 1-cent-per-ounce soda tax reduced the number of obesity cases, diabetes cases, and related complications. In addition, the soda tax policy implemented in California was cost-effective most of the time.

Highlights: Question: What remains unclear is whether the soda tax has an effect on health and health care costs.Findings: The 1-cent-per-ounce soda tax reduced the number of obesity cases, diabetes, and related complications. In addition, the soda tax policy brought large amounts of revenue.Meaning: This study provides additional evidence regarding the health care costs and cost-effectiveness related to the implementation of a soda tax.

导言。饮用含糖饮料(SSB)会导致体重增加、肥胖和糖尿病。有人建议征收苏打水税以减少 SSB 的消费。目前仍不清楚的是,苏打水税是否会对健康和医疗成本产生影响。我们评估了加利福尼亚州每盎司 1 美分苏打水税对肥胖症和糖尿病的成本效益。方法。采用微观模拟州过渡模型评估苏打税的成本效益。健康结果以质量调整生命年(QALYs)来衡量。预测了 2015 年至 2035 年的医疗成本。结果在模拟的加州成年人群中,苏打水税政策防止了 228 万例超重(95% 置信区间 [CI] -0.06 至 6.63)和 49 万例肥胖(95% 置信区间 -0.19 至 1.18)。从医疗保健角度来看,苏打水税的增量成本效益比为每 QALY 124,839 美元(95% CI -1,151,983 至 557,660 美元)。从医疗保健的角度来看,在使用每 QALY 100,000 美元的支付意愿阈值进行的概率敏感性分析中,苏打水税政策在 80% 的情况下具有成本效益。结论每盎司 1 美分的苏打水税降低了肥胖症、糖尿病和相关并发症的发病率。此外,加利福尼亚州实施的苏打水税政策在大多数情况下都具有成本效益:亮点:问题:苏打水税是否对健康和医疗成本有影响,目前仍不清楚:每盎司 1 美分的苏打税减少了肥胖症、糖尿病和相关并发症的数量。此外,苏打水税政策还带来了大量收入:本研究提供了有关实施苏打税的医疗成本和成本效益的更多证据。
{"title":"Evaluation of the Soda Tax on Obesity and Diabetes in California: A Cost-Effectiveness Analysis.","authors":"Fan Zhao, Risha Gidwani, May C Wang, Liwei Chen, Roch A Nianogo","doi":"10.1177/23814683241309669","DOIUrl":"10.1177/23814683241309669","url":null,"abstract":"<p><p><b>Introduction.</b> Consumption of sugar-sweetened beverages (SSBs) contributes to weight gain, obesity, and diabetes. Soda tax has been proposed to reduce consumption of SSBs. What remains unclear is whether the soda tax has an effect on health and health care costs. We evaluated the cost-effectiveness of a 1-cent-per-ounce soda tax on obesity and diabetes in California. <b>Methods.</b> A microsimulation state-transition model was used to evaluate the cost-effectiveness of the soda tax. Health outcomes were measured in quality-adjusted life-years (QALYs). Health care costs were projected from 2015 to 2035. <b>Results.</b> In a simulated cohort of Californian adults, the soda tax policy prevented 2.28 million cases of overweight (95% confidence interval [CI] -0.06 to 6.63) and 0.49 million cases of obesity (95% CI -0.19 to 1.18). From the health care perspective, the incremental cost-effectiveness ratio of the soda tax was $124,839 dollars per QALY (95% CI -1,151,983 to 557,660). From the health care perspective, the soda tax policy was cost-effective 80% of the time in the probabilistic sensitivity analysis using a willingness-to-pay threshold of $100,000 per QALY. <b>Conclusions.</b> The 1-cent-per-ounce soda tax reduced the number of obesity cases, diabetes cases, and related complications. In addition, the soda tax policy implemented in California was cost-effective most of the time.</p><p><strong>Highlights: </strong>Question: What remains unclear is whether the soda tax has an effect on health and health care costs.Findings: The 1-cent-per-ounce soda tax reduced the number of obesity cases, diabetes, and related complications. In addition, the soda tax policy brought large amounts of revenue.Meaning: This study provides additional evidence regarding the health care costs and cost-effectiveness related to the implementation of a soda tax.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"10 1","pages":"23814683241309669"},"PeriodicalIF":1.9,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Economic Modeling to Inform a Target Product Profile: A Case Study of a Novel Rapid Test for Clostridioides difficile Infection. 早期经济建模为目标产品简介提供信息:艰难梭菌感染新型快速检验的案例研究。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-22 eCollection Date: 2024-07-01 DOI: 10.1177/23814683241293739
Paola Cocco, Alison Florence Smith, Kerrie Ann Davies, Christopher Michael Rooney, Robert Michael West, Bethany Shinkins
<p><p><b>Background.</b> Target product profiles (TPPs) specify the essential properties tests must have to be able to address an unmet clinical need. <b>Aim.</b> To explore how early economic modeling can help to define TPP specifications based on cost-effectiveness considerations using the example of a new rapid diagnostic for <i>Clostridioides difficile</i> infection (CDI), a contagious health care-associated infection causing potentially fatal diarrhea. <b>Methods.</b> A resource-constrained simulation model was developed to compare a hypothetical test for CDI with current practice (i.e., test with glutamate dehydrogenase enzyme immunoassay first; if positive, test with polymerase chain reaction and cytotoxicity assay) for adult individuals with suspected CDI at the Leeds Teaching Hospital National Health System (NHS) Trust in the United Kingdom. Parameters are taken from UK-based observational data collected between 2018 and 2021, published literature, and expert opinion. A methodological framework was developed 1) to derive minimum diagnostic sensitivity and specificity and maximum price for different test turnaround-time values based on cost-effectiveness considerations from the health care perspective using the National Institute of Health Care Excellence willingness-to-pay threshold of £20,000 per quality-adjusted life-years and 2) to test their robustness using a series of sensitivity analyses. <b>Results.</b> A new rapid test for CDI with a 15-min turnaround time would require a minimum diagnostic sensitivity and specificity both equal to 96% and a maximum price of £44 to maintain cost-effectiveness compared with standard of care. <b>Conclusions.</b> This study provides a framework to inform the essential test properties based on cost-effectiveness considerations and to isolate the most influential model parameters and scenarios via a series of sensitivity analyses. These specifications, in turn, could be used to inform future TPPs for tests.</p><p><strong>Highlights: </strong>Target product profiles (TPPs) for new medical tests provide test developers with performance benchmarks and technical requirements for new tests. Early economic evaluation has already been used to identify acceptable ranges for certain performance requirements for new tests. Currently, however, early economic evaluation methods are yet to be used in the context of TPP development, and there is no guidance as to how this could and should be done.A de novo approach was developed to identify the minimum performance requirements and maximum costs for new tests, based on cost-effectiveness considerations, while also isolating most influential parameters. The added value of this framework lies in structuring early economic evaluation methods as a means of informing transparent, evidence-based minimum TPP performance specifications while also accounting as much as possible for the (inevitable) uncertainty surrounding the minimum performance requirements.This study repr
背景。目标产品简介(TPPs)规定了试验必须具备的基本特性,以满足尚未满足的临床需求。目的以艰难梭菌感染(CDI)的新型快速诊断方法为例,探讨早期经济建模如何有助于根据成本效益考虑确定 TPP 规格,艰难梭菌感染是一种与医疗保健相关的传染性感染,可导致潜在的致命性腹泻。方法。我们开发了一个资源受限的模拟模型,以比较假定的 CDI 检测方法与英国利兹教学医院国家卫生系统(NHS)信托基金对疑似 CDI 成人患者的现行做法(即先用谷氨酸脱氢酶酶免疫测定法进行检测;如果结果呈阳性,再用聚合酶链反应和细胞毒性检测法进行检测)。参数取自 2018 年至 2021 年间收集的英国观察数据、发表的文献和专家意见。制定了一个方法框架:1)基于成本效益的考虑,从医疗保健的角度,使用国家卫生保健卓越研究所的支付意愿阈值(每质量调整生命年 2 万英镑),得出不同检测周转时间值的最低诊断灵敏度和特异性以及最高价格;2)使用一系列敏感性分析来检验其稳健性。结果一种新的快速 CDI 检测方法需要 15 分钟的周转时间,其最低诊断灵敏度和特异性均需达到 96%,最高价格为 44 英镑,才能保持与标准医疗方法相比的成本效益。结论。本研究提供了一个框架,可根据成本效益考虑告知基本检验特性,并通过一系列敏感性分析分离出最有影响力的模型参数和方案。这些规范反过来又可用于为未来的试验产品简介提供依据:新医学检验的目标产品简介(TPP)为检验开发人员提供了新检验的性能基准和技术要求。早期经济评估已被用于确定新检验项目某些性能要求的可接受范围。目前,早期经济评价方法尚未被用于 TPP 的制定,也没有关于如何和应该如何进行早期经济评价的指导。我们开发了一种全新的方法,根据成本效益的考虑,确定新检验项目的最低性能要求和最高成本,同时还分离出影响最大的参数。这一框架的附加值在于,它将早期经济评估方法构建为一种手段,可为透明、循证的贸易点方案最低性能规格提供信息,同时尽可能考虑到围绕最低性能要求的(不可避免的)不确定性。本研究是首次应用早期经济建模作为一种手段,来得出未来贸易点方案中规定的艰难梭菌感染新型护理点检验的最低性能规格。
{"title":"Early Economic Modeling to Inform a Target Product Profile: A Case Study of a Novel Rapid Test for <i>Clostridioides difficile</i> Infection.","authors":"Paola Cocco, Alison Florence Smith, Kerrie Ann Davies, Christopher Michael Rooney, Robert Michael West, Bethany Shinkins","doi":"10.1177/23814683241293739","DOIUrl":"10.1177/23814683241293739","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Background.&lt;/b&gt; Target product profiles (TPPs) specify the essential properties tests must have to be able to address an unmet clinical need. &lt;b&gt;Aim.&lt;/b&gt; To explore how early economic modeling can help to define TPP specifications based on cost-effectiveness considerations using the example of a new rapid diagnostic for &lt;i&gt;Clostridioides difficile&lt;/i&gt; infection (CDI), a contagious health care-associated infection causing potentially fatal diarrhea. &lt;b&gt;Methods.&lt;/b&gt; A resource-constrained simulation model was developed to compare a hypothetical test for CDI with current practice (i.e., test with glutamate dehydrogenase enzyme immunoassay first; if positive, test with polymerase chain reaction and cytotoxicity assay) for adult individuals with suspected CDI at the Leeds Teaching Hospital National Health System (NHS) Trust in the United Kingdom. Parameters are taken from UK-based observational data collected between 2018 and 2021, published literature, and expert opinion. A methodological framework was developed 1) to derive minimum diagnostic sensitivity and specificity and maximum price for different test turnaround-time values based on cost-effectiveness considerations from the health care perspective using the National Institute of Health Care Excellence willingness-to-pay threshold of £20,000 per quality-adjusted life-years and 2) to test their robustness using a series of sensitivity analyses. &lt;b&gt;Results.&lt;/b&gt; A new rapid test for CDI with a 15-min turnaround time would require a minimum diagnostic sensitivity and specificity both equal to 96% and a maximum price of £44 to maintain cost-effectiveness compared with standard of care. &lt;b&gt;Conclusions.&lt;/b&gt; This study provides a framework to inform the essential test properties based on cost-effectiveness considerations and to isolate the most influential model parameters and scenarios via a series of sensitivity analyses. These specifications, in turn, could be used to inform future TPPs for tests.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Highlights: &lt;/strong&gt;Target product profiles (TPPs) for new medical tests provide test developers with performance benchmarks and technical requirements for new tests. Early economic evaluation has already been used to identify acceptable ranges for certain performance requirements for new tests. Currently, however, early economic evaluation methods are yet to be used in the context of TPP development, and there is no guidance as to how this could and should be done.A de novo approach was developed to identify the minimum performance requirements and maximum costs for new tests, based on cost-effectiveness considerations, while also isolating most influential parameters. The added value of this framework lies in structuring early economic evaluation methods as a means of informing transparent, evidence-based minimum TPP performance specifications while also accounting as much as possible for the (inevitable) uncertainty surrounding the minimum performance requirements.This study repr","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"9 2","pages":"23814683241293739"},"PeriodicalIF":1.9,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Booking Horizon Reduction on Cancellation Rates: An Experimental Analysis in Pediatric Outpatient Care. 缩短预约时间对取消率的影响:儿科门诊护理的实验分析》。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-18 eCollection Date: 2024-07-01 DOI: 10.1177/23814683241298673
Benjamin Ravenscroft, Hossein Abouee Mehrizi, Brendan Wylie-Toal

Background. The time between booking an appointment and the appointment taking place, known as lead time, has been identified as a predictor of cancellation and no-show probability in health care settings. Understanding the impact of reducing permissible lead times, that is, the booking horizon, at a policy level in an outpatient care setting is important when mitigating costly cancellation and no-show rates. Few studies have researched this in an observational or experimental setting. Methods. We leveraged longitudinal observational data from an outpatient pediatric rehabilitation organization in Ontario, Canada, consisting of 73,482 visits between June 2021 and October 2023. This organization reduced its booking horizon at the policy level from 12 to 4 wk in February 2023. Using 2 interrupted time-series approaches, we estimated the change in level, slope, and variance of the weekly combined last-minute cancellation and no-show rate associated with the policy change. Results. It is estimated that reducing the booking horizon is associated with an absolute reduction in the weekly rate of last-minute cancellations and no-shows of 1.02% to 1.85% (a relative reduction of 8.07%-15.70%). Furthermore, the variance dropped by 48.18%. Conclusion. Reducing the appointment booking horizon is associated with a significant reduction in the rate and variance of costly last-minute cancellations and no-shows. The reduced variance can also help enable effective usage of strategies such as overbooking for organizations seeking further approaches to mitigating the negative effects of no-shows.

Highlights: This study uses interrupted time-series approaches to assess the effects of reducing the appointment booking horizon at a policy level on last-minute cancellations and no-shows in a pediatric outpatient care setting.Reducing the permissible booking horizon from up to 3 mo to up to 4 wk is associated with a significant reduction in the rate of last-minute cancellations and no-shows.The shortened booking horizon policy is associated with a significant drop in the variance of last-minute cancellations and no-show rates, which is valuable in settings where overbooking occurs.

背景。在医疗机构中,从预约到就诊之间的时间被称为准备时间,是预测取消就诊和未就诊概率的一个因素。在门诊护理环境中,从政策层面了解缩短允许的准备时间(即预约时间)的影响,对于降低代价高昂的取消预约和爽约率非常重要。很少有研究在观察或实验环境中对此进行研究。研究方法我们利用了加拿大安大略省一家门诊儿科康复机构的纵向观察数据,其中包括 2021 年 6 月至 2023 年 10 月期间的 73482 次就诊。2023 年 2 月,该机构在政策层面上将预约期限从 12 周缩短为 4 周。我们使用两种间断时间序列方法,估算了与政策变化相关的每周最后一分钟取消率和未到率的水平、斜率和方差变化。结果。据估计,缩短预订期限可使每周最后一分钟取消和未到率的绝对值降低 1.02% 至 1.85%(相对值降低 8.07% 至 15.70%)。此外,方差下降了 48.18%。结论缩短预约时间可显著降低代价高昂的最后一刻取消预约和爽约的比率和差异。方差的减少还有助于企业有效利用超额预约等策略,从而进一步减轻爽约的负面影响:本研究采用间断时间序列方法,评估了在儿科门诊环境中,在政策层面上缩短预约时间对最后一分钟取消预约和爽约的影响。
{"title":"Effects of Booking Horizon Reduction on Cancellation Rates: An Experimental Analysis in Pediatric Outpatient Care.","authors":"Benjamin Ravenscroft, Hossein Abouee Mehrizi, Brendan Wylie-Toal","doi":"10.1177/23814683241298673","DOIUrl":"10.1177/23814683241298673","url":null,"abstract":"<p><p><b>Background.</b> The time between booking an appointment and the appointment taking place, known as lead time, has been identified as a predictor of cancellation and no-show probability in health care settings. Understanding the impact of reducing permissible lead times, that is, the booking horizon, at a policy level in an outpatient care setting is important when mitigating costly cancellation and no-show rates. Few studies have researched this in an observational or experimental setting. <b>Methods.</b> We leveraged longitudinal observational data from an outpatient pediatric rehabilitation organization in Ontario, Canada, consisting of 73,482 visits between June 2021 and October 2023. This organization reduced its booking horizon at the policy level from 12 to 4 wk in February 2023. Using 2 interrupted time-series approaches, we estimated the change in level, slope, and variance of the weekly combined last-minute cancellation and no-show rate associated with the policy change. <b>Results.</b> It is estimated that reducing the booking horizon is associated with an absolute reduction in the weekly rate of last-minute cancellations and no-shows of 1.02% to 1.85% (a relative reduction of 8.07%-15.70%). Furthermore, the variance dropped by 48.18%. <b>Conclusion.</b> Reducing the appointment booking horizon is associated with a significant reduction in the rate and variance of costly last-minute cancellations and no-shows. The reduced variance can also help enable effective usage of strategies such as overbooking for organizations seeking further approaches to mitigating the negative effects of no-shows.</p><p><strong>Highlights: </strong>This study uses interrupted time-series approaches to assess the effects of reducing the appointment booking horizon at a policy level on last-minute cancellations and no-shows in a pediatric outpatient care setting.Reducing the permissible booking horizon from up to 3 mo to up to 4 wk is associated with a significant reduction in the rate of last-minute cancellations and no-shows.The shortened booking horizon policy is associated with a significant drop in the variance of last-minute cancellations and no-show rates, which is valuable in settings where overbooking occurs.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"9 2","pages":"23814683241298673"},"PeriodicalIF":1.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Lung Cancer Screening Knowledge Associated with Patient-Centered Outcomes? A Multi-institutional Cohort Study. 肺癌筛查知识与以患者为中心的结果相关吗?一项多机构队列研究。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-17 eCollection Date: 2024-07-01 DOI: 10.1177/23814683241286884
Liana Schweiger, Sara E Golden, Donald R Sullivan, Ian Ilea, Sean P M Rice, Anne C Melzer, Santanu Datta, James M Davis, Christopher G Slatore

Introduction. The Centers for Medicare and Medicaid Services mandate that clinicians use a shared decision-making interaction to provide information about the harms and benefits of lung cancer screening (LCS). Methods. We enrolled patients from 3 geographically diverse medical centers after a decision-making interaction about undergoing LCS but before receiving a low-dose computed tomography (CT) scan. We performed the primary analysis based on the primary knowledge question, "Which of these conditions do you think that the CT scan screens for?" We used the knowledge summary score in secondary analyses. We evaluated LCS care experience by using validated instruments to measure participant-reported communication quality (Consultation Care Measure), perception of the primary LCS clinician (Consumer Assessment of Health Care Providers and Systems), and decision conflict (Decisional Conflict Scale). Results. Of the 409 participants, 44% correctly answered the primary LCS knowledge question. Clinician communication quality was rated positively by 93% of participants. Most (93%) participants rated their LCS clinician as good. Only 14% reported decision conflict. Correctly answering the primary LCS knowledge question was associated with higher patient-clinician communication quality scores (b = 0.4; 95% confidence interval [CI] [0.1, 0.7]; R 2 change = 0.03) and higher LCS clinician ratings (b = 0.4; 95% CI [0.0, 0.7]; R 2 change = 0.02) but not with decision conflict. In secondary analyses, higher total LCS knowledge score was associated with lower Decisional Conflict Scale scores (b = -2.2; 95% CI [-3.4, -0.9]; R 2 change = 0.24), indicating lower decision conflict. Conclusions. After an LCS decision-making interaction, many patients do not retain basic knowledge about LCS but nevertheless had low levels of decision conflict. Primary LCS knowledge may be important but insufficient to ensure high-quality, patient-centered LCS care.

Highlights: Survey of patients with a lung cancer screening (LCS) decision-making interaction.Only 44% of patients correctly answered the knowledge question about LCS.Primary LCS knowledge was not associated with decision conflict.Patient knowledge about LCS may not equate to high-quality patient-centered care.

导言。医疗保险和医疗补助服务中心规定,临床医生应采用共同决策互动的方式,提供有关肺癌筛查(LCS)危害和益处的信息。方法。我们从 3 个地理位置不同的医疗中心招募了在接受低剂量计算机断层扫描 (CT) 之前、经过肺癌筛查决策互动的患者。我们根据主要知识问题 "您认为 CT 扫描能筛查出哪些疾病?"进行了主要分析。我们在次要分析中使用了知识汇总得分。我们使用经过验证的工具来测量参与者报告的沟通质量(咨询护理测量)、对主要 LCS 临床医生的看法(医疗保健提供者和系统消费者评估)以及决策冲突(决策冲突量表),以此评估 LCS 护理体验。结果。在 409 名参与者中,44% 正确回答了初级 LCS 知识问题。93%的参与者对临床医生的沟通质量给予了积极评价。大多数参与者(93%)将他们的 LCS 临床医生评为 "好"。只有 14% 的参与者表示他们的决定存在冲突。正确回答主要 LCS 知识问题与较高的患者-临床医生沟通质量评分(b = 0.4;95% 置信区间 [CI] [0.1, 0.7];R 2 变化 = 0.03)和较高的 LCS 临床医生评分(b = 0.4;95% 置信区间 [CI] [0.0, 0.7];R 2 变化 = 0.02)相关,但与决策冲突无关。在二次分析中,较高的 LCS 知识总分与较低的决策冲突量表得分相关(b = -2.2; 95% CI [-3.4, -0.9];R 2 变化 = 0.24),表明决策冲突较低。结论在进行 LCS 决策互动后,许多患者没有保留有关 LCS 的基本知识,但决策冲突程度较低。基本的肺癌筛查知识可能很重要,但不足以确保高质量的、以患者为中心的肺癌筛查护理:对进行肺癌筛查(LCS)决策互动的患者进行了调查,只有 44% 的患者正确回答了有关 LCS 的知识问题,LCS 的基本知识与决策冲突无关。
{"title":"Is Lung Cancer Screening Knowledge Associated with Patient-Centered Outcomes? A Multi-institutional Cohort Study.","authors":"Liana Schweiger, Sara E Golden, Donald R Sullivan, Ian Ilea, Sean P M Rice, Anne C Melzer, Santanu Datta, James M Davis, Christopher G Slatore","doi":"10.1177/23814683241286884","DOIUrl":"10.1177/23814683241286884","url":null,"abstract":"<p><p><b>Introduction.</b> The Centers for Medicare and Medicaid Services mandate that clinicians use a shared decision-making interaction to provide information about the harms and benefits of lung cancer screening (LCS). <b>Methods.</b> We enrolled patients from 3 geographically diverse medical centers after a decision-making interaction about undergoing LCS but before receiving a low-dose computed tomography (CT) scan. We performed the primary analysis based on the primary knowledge question, \"Which of these conditions do you think that the CT scan screens for?\" We used the knowledge summary score in secondary analyses. We evaluated LCS care experience by using validated instruments to measure participant-reported communication quality (Consultation Care Measure), perception of the primary LCS clinician (Consumer Assessment of Health Care Providers and Systems), and decision conflict (Decisional Conflict Scale). <b>Results.</b> Of the 409 participants, 44% correctly answered the primary LCS knowledge question. Clinician communication quality was rated positively by 93% of participants. Most (93%) participants rated their LCS clinician as good. Only 14% reported decision conflict. Correctly answering the primary LCS knowledge question was associated with higher patient-clinician communication quality scores (b = 0.4; 95% confidence interval [CI] [0.1, 0.7]; <i>R</i> <sup>2</sup> change = 0.03) and higher LCS clinician ratings (b = 0.4; 95% CI [0.0, 0.7]; <i>R</i> <sup>2</sup> change = 0.02) but not with decision conflict. In secondary analyses, higher total LCS knowledge score was associated with lower Decisional Conflict Scale scores (b = -2.2; 95% CI [-3.4, -0.9]; <i>R</i> <sup>2</sup> change = 0.24), indicating lower decision conflict. <b>Conclusions.</b> After an LCS decision-making interaction, many patients do not retain basic knowledge about LCS but nevertheless had low levels of decision conflict. Primary LCS knowledge may be important but insufficient to ensure high-quality, patient-centered LCS care.</p><p><strong>Highlights: </strong>Survey of patients with a lung cancer screening (LCS) decision-making interaction.Only 44% of patients correctly answered the knowledge question about LCS.Primary LCS knowledge was not associated with decision conflict.Patient knowledge about LCS may not equate to high-quality patient-centered care.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"9 2","pages":"23814683241286884"},"PeriodicalIF":1.9,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11526162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"I Just Had to Do What I Had to Do": Characterizing Direct and Indirect Prostate Cancer Treatment Costs for Black Survivors and Their Caregivers. "我不得不做我必须做的事":黑人幸存者及其照顾者的直接和间接前列腺癌治疗成本特征。
IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-07 eCollection Date: 2024-07-01 DOI: 10.1177/23814683241282413
Hannah E Rice, Allison J L'Hotta, Amela Siječić, Bettina F Drake, Su-Hsin Chang, Eric H Kim, Robin Wright-Jones, Mellve Shahid, Camille Neal, Ashley J Housten

Introduction. Financial hardship is prevalent among Black prostate cancer survivors and exacerbates health disparities. Characterizing and sharing cost information with patients can facilitate well-informed treatment decision making. Our research explored the direct and indirect costs associated with prostate cancer treatment among Black men and their caregivers. Direct costs included out-of-pocket and insurance-related fees, and indirect costs included the unforeseen costs of care, including patient time, caregiver time, lost wages, and transportation. Methods. We conducted semi-structured interviews with Black prostate cancer survivors and their caregivers to learn about the experience of direct and indirect costs. The interview guide and data analysis were informed by the Measures of Financial Wellbeing framework to gain a better understanding of the material, behavioral, and psychosocial aspects of care-related costs. Guided by a qualitative descriptive approach, we used inductive and deductive coding for our thematic analysis. Results. Eleven prostate cancer survivors with a median age of 68 y (interquartile range [IQR] 62.0-71.5 y) and 11 caregivers with a median age of 64 y (IQR 58.5-70.5 y) participated. We grouped themes into 3 domains and their intersections (i.e., material, behavioral, psychosocial). Participants reported their work and insurance had a significant influence on their finances, treatment costs required rearranging of household budgets, and the weight of indirect costs varied. Ultimately, participants emphasized the significant impact of care costs and the adjustments needed to adapt to them. Discussion. The complexities of material, behavioral, and psychosocial domains of direct and indirect costs of prostate cancer are critical to address when supporting those diagnosed with prostate cancer when making preference-sensitive treatment decisions. The interconnectedness between indirect costs highlights the wide-ranging impact financial well-being has on prostate cancer survivors and caregivers.

Highlights: Direct and indirect costs have a wide-ranging impact on the material, behavioral, and psychosocial aspects of financial well-being of Black prostate cancer survivors and their caregivers.These results emphasize the need for sharing cost information to support medical decision making.Future research should focus on the design of cost-sharing interventions that target the complexities of direct and indirect costs collectively, rather than separately.

导言。经济困难在前列腺癌黑人幸存者中十分普遍,并加剧了健康差异。了解并与患者分享费用信息有助于患者在充分知情的情况下做出治疗决策。我们的研究探讨了黑人男性及其照顾者在前列腺癌治疗过程中的直接和间接费用。直接成本包括自付费用和保险相关费用,间接成本包括不可预见的护理成本,包括患者时间、护理人员时间、误工费和交通费。方法。我们对黑人前列腺癌幸存者及其护理人员进行了半结构化访谈,以了解他们在直接和间接成本方面的经历。访谈指南和数据分析参考了 "财务状况衡量标准 "框架,以更好地了解与护理相关的费用的物质、行为和社会心理方面。在定性描述法的指导下,我们采用归纳和演绎编码法进行主题分析。研究结果11名前列腺癌幸存者(中位数年龄为68岁(四分位距[IQR]为62.0-71.5岁))和11名护理者(中位数年龄为64岁(四分位距[IQR]为58.5-70.5岁))参与了分析。我们将主题分为 3 个领域及其交叉点(即物质、行为和社会心理)。参与者表示,他们的工作和保险对他们的财务状况有很大影响,治疗费用需要重新安排家庭预算,间接费用的比重也各不相同。最后,与会者强调了护理费用的重大影响以及为适应这些费用所需的调整。讨论。前列腺癌的直接和间接成本涉及物质、行为和社会心理等多个领域,其复杂性是支持前列腺癌患者做出偏好敏感型治疗决策的关键。间接成本之间的相互联系凸显了经济福祉对前列腺癌幸存者和护理者的广泛影响:直接成本和间接成本对黑人前列腺癌幸存者及其照顾者的物质、行为和社会心理方面的财务状况产生了广泛的影响。这些结果强调了共享成本信息以支持医疗决策的必要性。未来的研究应侧重于设计成本分担干预措施,以共同而非单独应对直接成本和间接成本的复杂性。
{"title":"\"I Just Had to Do What I Had to Do\": Characterizing Direct and Indirect Prostate Cancer Treatment Costs for Black Survivors and Their Caregivers.","authors":"Hannah E Rice, Allison J L'Hotta, Amela Siječić, Bettina F Drake, Su-Hsin Chang, Eric H Kim, Robin Wright-Jones, Mellve Shahid, Camille Neal, Ashley J Housten","doi":"10.1177/23814683241282413","DOIUrl":"10.1177/23814683241282413","url":null,"abstract":"<p><p><b>Introduction.</b> Financial hardship is prevalent among Black prostate cancer survivors and exacerbates health disparities. Characterizing and sharing cost information with patients can facilitate well-informed treatment decision making. Our research explored the direct and indirect costs associated with prostate cancer treatment among Black men and their caregivers. Direct costs included out-of-pocket and insurance-related fees, and indirect costs included the unforeseen costs of care, including patient time, caregiver time, lost wages, and transportation. <b>Methods.</b> We conducted semi-structured interviews with Black prostate cancer survivors and their caregivers to learn about the experience of direct and indirect costs. The interview guide and data analysis were informed by the Measures of Financial Wellbeing framework to gain a better understanding of the material, behavioral, and psychosocial aspects of care-related costs. Guided by a qualitative descriptive approach, we used inductive and deductive coding for our thematic analysis. <b>Results.</b> Eleven prostate cancer survivors with a median age of 68 y (interquartile range [IQR] 62.0-71.5 y) and 11 caregivers with a median age of 64 y (IQR 58.5-70.5 y) participated. We grouped themes into 3 domains and their intersections (i.e., material, behavioral, psychosocial). Participants reported their work and insurance had a significant influence on their finances, treatment costs required rearranging of household budgets, and the weight of indirect costs varied. Ultimately, participants emphasized the significant impact of care costs and the adjustments needed to adapt to them. <b>Discussion.</b> The complexities of material, behavioral, and psychosocial domains of direct and indirect costs of prostate cancer are critical to address when supporting those diagnosed with prostate cancer when making preference-sensitive treatment decisions. The interconnectedness between indirect costs highlights the wide-ranging impact financial well-being has on prostate cancer survivors and caregivers.</p><p><strong>Highlights: </strong>Direct and indirect costs have a wide-ranging impact on the material, behavioral, and psychosocial aspects of financial well-being of Black prostate cancer survivors and their caregivers.These results emphasize the need for sharing cost information to support medical decision making.Future research should focus on the design of cost-sharing interventions that target the complexities of direct and indirect costs collectively, rather than separately.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"9 2","pages":"23814683241282413"},"PeriodicalIF":1.9,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
MDM Policy and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1